NONINVASIVE ASSESSMENT OF BRONCHIAL INFLAMMATION IN ASTHMA - NO CORRELATION BETWEEN EOSINOPHILIA OF INDUCED SPUTUM AND BRONCHIAL RESPONSIVENESS TO INHALED HYPERTONIC SALINE
Mj. Iredale et al., NONINVASIVE ASSESSMENT OF BRONCHIAL INFLAMMATION IN ASTHMA - NO CORRELATION BETWEEN EOSINOPHILIA OF INDUCED SPUTUM AND BRONCHIAL RESPONSIVENESS TO INHALED HYPERTONIC SALINE, Clinical and experimental allergy, 24(10), 1994, pp. 940-945
Bronchial inflammation in mild asthma has been investigated using bron
choscopical techniques. The safety of bronchoscopy in patients with mo
re severe asthma has been questioned. We have used the non-invasive te
chnique of hypertonic saline (HS) inhalation to induce sputum samples
for cellular analysis whilst simultaneously yielding a measure of bron
chial responsiveness. Ten normal subjects and a heterogenous group of
24 asthmatic patients (range % predicted FEV(1) 43.3-111.5) underwent
HS challenge. Sputum samples induced were analysed. Total and differen
tial cell counts between the two groups were compared. The association
between bronchial responsiveness to HS and sputum cell counts was exa
mined in the asthma group. Mean maximum fall in FEV(1) for normal subj
ects was 4.0(2.1-5.9, 95%Cl)% after saline. Geometric mean PD20HS for
asthma patients was 7.7 (range 0.68-40.92) ml. Adequate sputum samples
were obtained from 9/10 normals and 23/24 asthmatic patients. Sputum
from normal subjects contained a median of 3.8 (2.8-8.1, interquartile
range)% eosinophils compared with 17.6 (8.9-34.1)% in sputum from ast
hma patients (P < 0.001). Sputum from asthma patients contained fewer
of all other cell types compared with normals, with the difference in
macrophages reaching significance. There was no correlation between PD
20HS and cell count for any cell type in asthma subjects. Analysis of
induced sputum represents a simple, safe, non-invasive and well-tolera
ted method of assessment of bronchial inflammation, suitable for use i
n patients with a range of asthma severity. There was no relationship
between inflammation, as assessed by sputum cell counts and a measure
of 'indirect' bronchial responsiveness.